IVERIC bio (ISEE) Stock Highlights

39.95 | +0%

2023-08-10 15:49:52

IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

Statistics

Range Today

39.95 39.95

Volume Today 0

Range 1 Year

9.39 39.99

Volume 1 Year 997.09M

Range 3 Year

3.97 39.99

Volume 3 Year 1.86B

Range 10 Year

0.906 80

Volume 10 Year 2.87B

Highlights

Market Capitalization 5.51B (mid)

Current Price 39.95

Performance

Latest 0%

1 Month +4.44%

3 Months +42.98%

6 Months +107.53%

1 Year +254.48%

3 Years +783.85%

5 Years +1363.37%

10 Years +73.24%

Benchmarks

Market Capitalization

32 / 368

Gross Profits

243 / 278

Total Revenue

0 / 300

Total Rank

168 / 368

Free Cashflow

0 / 352

Performance 5 years

5 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.